Literature DB >> 28150485

Obesity and cardiovascular diseases.

Sergey Kachur1, Carl J Lavie2, Alban de Schutter3, Richard V Milani2, Hector O Ventura2.   

Abstract

Obesity is increasingly more common in postindustrial societies, and the burden of childhood obesity is increasing. The major effects of obesity on cardiovascular (CV) health are mediated through the risk of metabolic syndrome (insulin-resistance, dyslipidemia, and hypertension), such that an absence of these risk factors in obese individuals may not be associated with increased mortality risk. In individuals already diagnosed with chronic CV disease (CVD), the overweight and class I obese have significant associations with improved survival. However, this effect is attenuated by increases in cardiorespiratory fitness. The negative effects of obesity on CV health manifest as accelerated progression of atherosclerosis, higher rates of ventricular remodeling and a higher risk of associated diseases, including stroke, myocardial infarction, and heart failure. The most effective therapies at reversing CVD risk factors associated with obesity have been dietary changes with exercise, especially through structured exercise programs, such as cardiac rehabilitation.

Entities:  

Mesh:

Year:  2017        PMID: 28150485     DOI: 10.23736/S0026-4806.17.05022-4

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  53 in total

Review 1.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

Review 2.  Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Authors:  Jiri Polivka; Jiri Polivka; Martin Pesta; Vladimir Rohan; Libuse Celedova; Smit Mahajani; Ondrej Topolcan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2019-02-20       Impact factor: 6.543

Review 3.  Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment.

Authors:  Liaosadat Mirsafaei; Željko Reiner; Rana Shafabakhsh; Zatollah Asemi
Journal:  Plant Foods Hum Nutr       Date:  2020-09       Impact factor: 3.921

4.  Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition.

Authors:  Alessandro Bitto; Nicole Tatom; Thomas Krivak; Peter Grotz; Matt Kaeberlein
Journal:  Front Aging       Date:  2021-09-27

5.  Mechanisms of reduced leptin-mediated satiety signaling during obesity.

Authors:  Sung Jin Park; Yang Yu; Carter G Zides; Michael J Beyak
Journal:  Int J Obes (Lond)       Date:  2022-03-03       Impact factor: 5.551

6.  The Impact of Bariatric Surgery on Cardiopulmonary Function: Analyzing VO2 Recovery Kinetics.

Authors:  Maria Inês Remígio; Fernando Santa Cruz; Álvaro Ferraz; Maria Cecília Remígio; Giordano Parente; Igor Nascimento; Daniella Brandão; Armele de Fatima Dornelas de Andrade; Fernando de Moraes Neto; Josemberg Campos
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

7.  Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats.

Authors:  Chayodom Maneechote; Siripong Palee; Sasiwan Kerdphoo; Thidarat Jaiwongkam; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Acta Pharmacol Sin       Date:  2021-03-12       Impact factor: 6.150

8.  JNK-dependent phosphorylation and nuclear translocation of EGR-1 promotes cardiomyocyte apoptosis.

Authors:  Jinrun Zhou; Yujuan Yao; Jiaojiao Zhang; Zhaohui Wang; Tianshu Zheng; Yao Lu; Weihua Kong; Jing Zhao
Journal:  Apoptosis       Date:  2022-02-01       Impact factor: 4.677

9.  Association of Region-Specific Cardiac Adiposity With Dysglycemia and New-Onset Diabetes.

Authors:  Kuo-Tzu Sung; Jen-Yuan Kuo; Chun-Ho Yun; Yueh-Hung Lin; Jui-Peng Tsai; Chi-In Lo; Chih-Chung Hsiao; Yau-Huei Lai; Cheng-Ting Tsai; Charles Jia-Yin Hou; Cheng-Huang Su; Hung-I Yeh; Chen-Yen Chien; Ta-Chuan Hung; Chung-Lieh Hung
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 6.106

10.  Jian Pi Tiao Gan Yin alleviates obesity phenotypes through mTORC1/SREBP1 signaling in vitro and in vivo.

Authors:  Xiaoming Song; Lulu Han; Xiaowan Lin; Minghui Tian; Fenglei Sun; Bo Feng
Journal:  Ann Transl Med       Date:  2022-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.